OCRELIZUMAB AND HYALURONIDASE

OCRELIZUMAB AND HYALURONIDASE was reported 499 times

OCRELIZUMAB AND HYALURONIDASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DESQUAMATIVE INFLAMMATORY VAGINITIS 1 0.0455
1 EPINEPHRINE DECREASED 1 0.0435
2 ADMINISTRATION SITE PRURITUS 1 0.0078
3 ADMINISTRATION SITE IRRITATION 1 0.0071
4 PARAGANGLION NEOPLASM 1 0.0068
5 GRANULOCYTOSIS 1 0.0051
6 VESTIBULAR MIGRAINE 1 0.0041
7 PATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0033
8 INJECTION RELATED REACTION 5 0.0030
9 VITAMIN B1 DEFICIENCY 1 0.0023
10 INFUSION SITE HAEMATOMA 1 0.0021
11 UTERINE CYST 1 0.0018
12 DYSMETRIA 1 0.0017
13 B-LYMPHOCYTE COUNT DECREASED 2 0.0015
14 FACIAL DISCOMFORT 1 0.0014
15 THROMBOTIC STROKE 1 0.0014
16 STOMACH MASS 1 0.0013
17 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
18 PATERNAL EXPOSURE DURING PREGNANCY 1 0.0012
19 CARDIAC OUTPUT DECREASED 1 0.0011
20 VAGINAL DISORDER 1 0.0010
21 BONE SWELLING 1 0.0010
22 ANTIBIOTIC THERAPY 1 0.0010
23 INJECTION SITE DISCHARGE 5 0.0009
24 ADMINISTRATION SITE PAIN 1 0.0009
25 JC POLYOMAVIRUS TEST POSITIVE 1 0.0009
26 WHITE MATTER LESION 1 0.0008
27 JOINT INSTABILITY 1 0.0007
28 ELECTRIC SHOCK SENSATION 2 0.0007
29 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
30 NOROVIRUS INFECTION 1 0.0007
31 VASCULAR INJURY 1 0.0007
32 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
33 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
34 MENTAL FATIGUE 1 0.0007
35 INJECTION SITE OEDEMA 1 0.0006
36 SCHIZOAFFECTIVE DISORDER 1 0.0006
37 MONOPARESIS 1 0.0006
38 MYELOPATHY 1 0.0005
39 DEMYELINATION 2 0.0005
40 HYPERPARATHYROIDISM 1 0.0005
41 SKIN INDURATION 1 0.0005
42 MUSCLE FATIGUE 2 0.0005
43 LIMB MASS 1 0.0005
44 BRAIN FOG 7 0.0004
45 INJECTION SITE ERYTHEMA 53 0.0004
46 SLOW SPEECH 1 0.0004
47 ABDOMINAL MASS 1 0.0004
48 CLUMSINESS 1 0.0004
49 HICCUPS 3 0.0004
50 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
51 MULTIPLE SCLEROSIS RELAPSE 25 0.0004
52 INJECTION SITE SCAR 1 0.0004
53 FIBULA FRACTURE 1 0.0003
54 EYELID MARGIN CRUSTING 1 0.0003
55 VOMITING PROJECTILE 1 0.0003
56 ATYPICAL PNEUMONIA 1 0.0003
57 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
58 INJECTION SITE DISCOLOURATION 4 0.0003
59 INJECTION SITE REACTION 22 0.0003
60 BLOOD CREATININE DECREASED 1 0.0003
61 BLADDER DISORDER 3 0.0003
62 TEMPERATURE INTOLERANCE 3 0.0003
63 INJECTION SITE DISCOMFORT 3 0.0003
64 EAR PRURITUS 1 0.0003
65 APPENDICECTOMY 1 0.0003
66 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
67 SENSITIVE SKIN 2 0.0003
68 FREEZING PHENOMENON 1 0.0003
69 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
70 PROTEIN TOTAL DECREASED 1 0.0003
71 PARANASAL SINUS HYPERSECRETION 1 0.0003
72 MUSCLE RUPTURE 1 0.0003
73 TRIGEMINAL NEURALGIA 1 0.0002
74 SENSORY LOSS 2 0.0002
75 CONTUSION 23 0.0002
76 ABDOMINAL PAIN LOWER 6 0.0002
77 INFUSION SITE PAIN 3 0.0002
78 INJECTION SITE RASH 7 0.0002
79 COLD SWEAT 4 0.0002
80 IMMUNOSUPPRESSION 2 0.0002
81 THROAT TIGHTNESS 6 0.0002
82 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
83 INJECTION SITE PAPULE 1 0.0002
84 INJECTION SITE PAIN 66 0.0002
85 INJECTION SITE SWELLING 16 0.0002
86 RASH VESICULAR 1 0.0002
87 PHARYNGEAL SWELLING 2 0.0002
88 ABDOMINAL TENDERNESS 1 0.0002
89 INJECTION SITE INFLAMMATION 1 0.0002
90 THROAT IRRITATION 9 0.0002
91 MUSCULOSKELETAL CHEST PAIN 3 0.0002
92 SWELLING 18 0.0002
93 TENDERNESS 2 0.0002
94 MULTIPLE SCLEROSIS 9 0.0002
95 BRUXISM 1 0.0002
96 ASTHENOPIA 1 0.0002
97 DEAFNESS UNILATERAL 1 0.0002
98 PERONEAL NERVE PALSY 1 0.0002
99 SKIN WARM 1 0.0002
100 ENERGY INCREASED 1 0.0002
101 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
102 INJECTION SITE VESICLES 1 0.0002
103 MENISCUS INJURY 1 0.0002
104 NO ADVERSE EVENT 29 0.0002
105 INFUSION SITE SWELLING 1 0.0002
106 INJECTION SITE INDURATION 2 0.0002
107 DYSGRAPHIA 1 0.0002
108 IMMUNE SYSTEM DISORDER 2 0.0002
109 MENINGITIS 1 0.0001
110 PRODUCT ADMINISTRATION ERROR 3 0.0001
111 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
112 BLOOD TESTOSTERONE DECREASED 1 0.0001
113 EYE MOVEMENT DISORDER 1 0.0001
114 INJECTION SITE WARMTH 3 0.0001
115 LYMPHOEDEMA 1 0.0001
116 HYPERTRANSAMINASAEMIA 1 0.0001
117 MASS 2 0.0001
118 SEASONAL ALLERGY 2 0.0001
119 FEAR OF INJECTION 1 0.0001
120 INFUSION RELATED REACTION 9 0.0001
121 CEREBRAL DISORDER 1 0.0001
122 ARTHROPOD BITE 1 0.0001
123 INJECTION SITE PRURITUS 9 0.0001
124 IMMUNODEFICIENCY 2 0.0001
125 ATRIOVENTRICULAR BLOCK 1 0.0001
126 BLOOD ALBUMIN DECREASED 1 0.0001
127 GINGIVAL PAIN 1 0.0001
128 INJECTION SITE BRUISING 10 0.0001
129 FRUSTRATION TOLERANCE DECREASED 1 0.0001
130 ESCHERICHIA INFECTION 1 0.0001
131 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
132 FACIAL PARALYSIS 1 0.0001
133 SCAR 2 0.0001
134 BLOOD CALCIUM INCREASED 1 0.0001
135 LYMPHOCYTE COUNT DECREASED 2 0.0001
136 ANAL INCONTINENCE 1 0.0001
137 OPTIC NEURITIS 1 0.0001
138 APPENDICITIS 1 0.0001
139 ERYTHEMA 22 0.0001
140 SPINAL DISORDER 1 0.0001
141 VITAMIN D DEFICIENCY 1 0.0001
142 HYPOTONIA 1 0.0001
143 BURNING SENSATION 7 0.0001
144 DRY THROAT 1 0.0001
145 BODY TEMPERATURE INCREASED 2 0.0001
146 PRODUCT PREPARATION ERROR 2 0.0001
147 POOR VENOUS ACCESS 1 0.0001
148 WEIGHT FLUCTUATION 1 0.0001
149 BODY HEIGHT DECREASED 1 0.0001
150 DECREASED ACTIVITY 1 0.0001
151 TOOTH FRACTURE 1 0.0001
152 SKIN INFECTION 1 0.0001
153 OCULAR DISCOMFORT 1 0.0001
154 FLUSHING 9 0.0001
155 SKIN DISCOLOURATION 4 0.0001
156 INFLUENZA LIKE ILLNESS 7 0.0001
157 COVID-19 PNEUMONIA 1 0.0001
158 DISCOMFORT 5 0.0001
159 MUSCLE SPASTICITY 1 0.0001
160 INJECTION SITE IRRITATION 1 0.0001
161 SARS-COV-2 TEST POSITIVE 1 0.0001
162 BLOOD PRESSURE DECREASED 5 0.0001
163 PALLOR 2 0.0001
164 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
165 ANAPHYLACTIC REACTION 4 0.0001
166 HUNGER 1 0.0001
167 PARAESTHESIA ORAL 1 0.0001
168 DYSPHONIA 4 0.0001
169 NASAL CONGESTION 4 0.0001
170 URINARY INCONTINENCE 2 0.0001
171 COLON CANCER 1 0.0001
172 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
173 OSTEOPENIA 1 0.0001
174 DEVICE FAILURE 1 0.0001
175 PAIN 40 0.0001
176 MIGRAINE 6 0.0001
177 CYSTITIS 2 0.0001
178 OBESITY 1 0.0001
179 SENSORY DISTURBANCE 1 0.0001
180 NIGHT SWEATS 2 0.0001
181 FATIGUE 48 0.0001
182 MUSCULAR WEAKNESS 7 0.0001
183 GAIT INABILITY 2 0.0001
184 MUSCULOSKELETAL DISCOMFORT 1 0.0001
185 ABDOMINAL DISTENSION 6 0.0001
186 PARAESTHESIA 9 0.0001
187 PRODUCT STORAGE ERROR 5 0.0001
188 GASTROENTERITIS VIRAL 1 0.0001
189 RASH 24 0.0001
190 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
191 INJECTION SITE MASS 2 0.0001
192 HYPOAESTHESIA 8 0.0001
193 EAR PAIN 1 0.0001
194 SINUS DISORDER 1 0.0001
195 URTICARIA 8 0.0000
196 ABDOMINAL PAIN 11 0.0000
197 IRRITABLE BOWEL SYNDROME 1 0.0000
198 RHINORRHOEA 3 0.0000
199 AMNESIA 3 0.0000
200 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
201 SNEEZING 1 0.0000
202 PAIN IN EXTREMITY 13 0.0000
203 LOCALISED INFECTION 1 0.0000
204 MENTAL IMPAIRMENT 1 0.0000
205 FIBROMYALGIA 1 0.0000
206 NEURALGIA 1 0.0000
207 URINARY TRACT INFECTION 7 0.0000
208 INJECTION SITE URTICARIA 1 0.0000
209 HEADACHE 25 0.0000
210 CELLULITIS 2 0.0000
211 ILLNESS 4 0.0000
212 BACK PAIN 9 0.0000
213 HAEMATOMA 1 0.0000
214 DEAFNESS 1 0.0000
215 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
216 PRURITUS 14 0.0000
217 DIVERTICULITIS 1 0.0000
218 NECK PAIN 2 0.0000
219 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
220 PAIN IN JAW 1 0.0000
221 DYSSTASIA 1 0.0000
222 PALPITATIONS 4 0.0000
223 PSYCHOTIC DISORDER 1 0.0000
224 RESPIRATORY DISORDER 1 0.0000
225 OFF LABEL USE 29 0.0000
226 LACRIMATION INCREASED 1 0.0000
227 ILL-DEFINED DISORDER 2 0.0000
228 FEELING HOT 2 0.0000
229 NASOPHARYNGITIS 6 0.0000
230 NERVOUS SYSTEM DISORDER 1 0.0000
231 HEAD INJURY 1 0.0000
232 MOVEMENT DISORDER 1 0.0000
233 HIP FRACTURE 1 0.0000
234 HEART RATE INCREASED 3 0.0000
235 VIRAL INFECTION 1 0.0000
236 FUNGAL INFECTION 1 0.0000
237 SKIN DISORDER 1 0.0000
238 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
239 CHEST DISCOMFORT 3 0.0000
240 VISION BLURRED 4 0.0000
241 DELIRIUM 1 0.0000
242 HEART RATE DECREASED 1 0.0000
243 SLEEP DISORDER 2 0.0000
244 RESTLESSNESS 1 0.0000
245 HYPERSENSITIVITY 5 0.0000
246 DYSGEUSIA 2 0.0000
247 INFLUENZA 3 0.0000
248 DYSARTHRIA 1 0.0000
249 COLITIS 1 0.0000
250 INSOMNIA 7 0.0000
251 GAIT DISTURBANCE 5 0.0000
252 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
253 CHILLS 3 0.0000
254 BLINDNESS 1 0.0000
255 NEUTROPHIL COUNT DECREASED 1 0.0000
256 OSTEOPOROSIS 1 0.0000
257 TREMOR 4 0.0000
258 POLLAKIURIA 1 0.0000
259 ABDOMINAL DISCOMFORT 4 0.0000
260 HYPOACUSIS 1 0.0000
261 BALANCE DISORDER 2 0.0000
262 MUSCULOSKELETAL STIFFNESS 2 0.0000
263 COVID-19 4 0.0000
264 TACHYCARDIA 2 0.0000
265 DRY SKIN 3 0.0000
266 GASTROINTESTINAL DISORDER 2 0.0000
267 MEMORY IMPAIRMENT 3 0.0000
268 NEPHROLITHIASIS 1 0.0000
269 TINNITUS 1 0.0000
270 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
271 OROPHARYNGEAL PAIN 2 0.0000
272 RENAL DISORDER 1 0.0000
273 COGNITIVE DISORDER 1 0.0000
274 BLOOD GLUCOSE INCREASED 4 0.0000
275 OCULAR HYPERAEMIA 1 0.0000
276 RASH ERYTHEMATOUS 1 0.0000
277 DRUG INTOLERANCE 2 0.0000
278 MALAISE 9 0.0000
279 AGGRESSION 1 0.0000
280 SOMNOLENCE 4 0.0000
281 FLUID RETENTION 1 0.0000
282 BLOOD PRESSURE INCREASED 3 0.0000
283 SINUSITIS 2 0.0000
284 THERAPY CESSATION 1 0.0000
285 INFLAMMATION 1 0.0000
286 SPEECH DISORDER 1 0.0000
287 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
288 RASH PRURITIC 1 0.0000
289 OEDEMA 1 0.0000
290 HAEMATOCHEZIA 1 0.0000
291 MEDICATION ERROR 1 0.0000
292 BLISTER 1 0.0000
293 OXYGEN SATURATION DECREASED 1 0.0000
294 FLATULENCE 1 0.0000
295 HERPES ZOSTER 1 0.0000
296 SEIZURE 2 0.0000
297 DISEASE PROGRESSION 2 0.0000
298 CATARACT 1 0.0000
299 IRRITABILITY 1 0.0000
300 THERAPEUTIC RESPONSE DECREASED 1 0.0000
301 SUICIDE ATTEMPT 1 0.0000
302 PLEURAL EFFUSION 1 0.0000
303 VERTIGO 1 0.0000
304 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
305 HYPERHIDROSIS 2 0.0000
306 PNEUMONIA 5 0.0000
307 DEEP VEIN THROMBOSIS 1 0.0000
308 SWELLING FACE 1 0.0000
309 ALOPECIA 3 0.0000
310 FEBRILE NEUTROPENIA 1 0.0000
311 FALL 5 0.0000
312 VOMITING 7 0.0000
313 ABDOMINAL PAIN UPPER 3 0.0000
314 PYREXIA 5 0.0000
315 ARTHRALGIA 6 0.0000
316 WEIGHT DECREASED 4 0.0000
317 COUGH 4 0.0000
318 ANXIETY 4 0.0000
319 SKIN BURNING SENSATION 1 0.0000
320 BRONCHITIS 1 0.0000
321 ASTHENIA 5 0.0000
322 HALLUCINATION 1 0.0000
323 HOT FLUSH 1 0.0000
324 DEPRESSION 3 0.0000
325 DIABETES MELLITUS 1 0.0000
326 PERIPHERAL SWELLING 2 0.0000
327 NAUSEA 10 0.0000
328 THROMBOSIS 1 0.0000
329 ADVERSE DRUG REACTION 1 0.0000
330 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
331 DIARRHOEA 7 0.0000
332 BREAST CANCER 1 0.0000
333 DYSPHAGIA 1 0.0000
334 PRODUCT DOSE OMISSION ISSUE 3 0.0000
335 DIZZINESS 5 0.0000
336 SYNCOPE 1 0.0000
337 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
338 DRUG INEFFECTIVE 12 0.0000
339 SEPSIS 1 0.0000
340 ASTHMA 1 0.0000
341 DYSPNOEA 5 0.0000
342 RHEUMATOID ARTHRITIS 1 0.0000
343 FEELING ABNORMAL 2 0.0000
344 JOINT SWELLING 1 0.0000
345 EMOTIONAL DISTRESS 1 0.0000
346 VISUAL IMPAIRMENT 1 0.0000
347 DEHYDRATION 1 0.0000
348 NEUTROPENIA 1 0.0000
349 INFECTION 1 0.0000
350 CONFUSIONAL STATE 1 0.0000
351 MYALGIA 1 0.0000
352 MYOCARDIAL INFARCTION 1 0.0000
353 MUSCLE SPASMS 1 0.0000
354 CHEST PAIN 1 0.0000
355 HYPERTENSION 1 0.0000
356 CONSTIPATION 1 0.0000
357 DEATH 1 0.0000